HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N-arachidonoyl-L-serine is neuroprotective after traumatic brain injury by reducing apoptosis.

Abstract
N-arachidonoyl-L-serine (AraS) is a brain component structurally related to the endocannabinoid family. We investigated the neuroprotective effects of AraS following closed head injury induced by weight drop onto the exposed fronto-parietal skull and the mechanisms involved. A single injection of AraS following injury led to a significant improvement in functional outcome, and to reduced edema and lesion volume compared with vehicle. Specific antagonists to CB2 receptors, transient receptor potential vanilloid 1 (TRPV1) or large conductance calcium-activated potassium (BK) channels reversed these effects. Specific binding assays did not indicate binding of AraS to the GPR55 cannabinoid receptor. N-arachidonoyl-L-serine blocked the attenuation in phosphorylated extracellular-signal-regulated kinase 1/2 (ERK) levels and led to an increase in pAkt in both the ipsilateral and contralateral cortices. Increased levels of the prosurvival factor Bcl-xL were evident 24 hours after injury in AraS-treated mice, followed by a 30% reduction in caspase-3 activity, measured 3 days after injury. Treatment with a CB2 antagonist, but not with a CB1 antagonist, reversed this effect. Our results suggest that administration of AraS leads to neuroprotection via ERK and Akt phosphorylation and induction of their downstream antiapoptotic pathways. These protective effects are related mostly to indirect signaling via the CB2R and TRPV1 channels but not through CB1 or GPR55 receptors.
AuthorsAyelet Cohen-Yeshurun, Victoria Trembovler, Alexander Alexandrovich, Erik Ryberg, Peter J Greasley, Raphael Mechoulam, Esther Shohami, Ronen R Leker
JournalJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (J Cereb Blood Flow Metab) Vol. 31 Issue 8 Pg. 1768-77 (Aug 2011) ISSN: 1559-7016 [Electronic] United States
PMID21505478 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Arachidonic Acids
  • N-arachidonoyl L-serine
  • Neuroprotective Agents
  • Receptor, Cannabinoid, CB2
  • TRPV Cation Channels
  • TRPV1 receptor
  • Serine
  • Proto-Oncogene Proteins c-akt
  • Mitogen-Activated Protein Kinase 3
Topics
  • Animals
  • Apoptosis (drug effects)
  • Arachidonic Acids (pharmacology, therapeutic use)
  • Brain Injuries (drug therapy, pathology)
  • Male
  • Mice
  • Mitogen-Activated Protein Kinase 3 (metabolism)
  • Neuroprotective Agents
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Receptor, Cannabinoid, CB2 (metabolism)
  • Recovery of Function
  • Serine (analogs & derivatives, pharmacology, therapeutic use)
  • TRPV Cation Channels (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: